North America Western Blotting Market Trends, Size, Segment and Growth by Forecast to 2030

 North America Western Blotting Market Outlook (2019-2027)

The North American western blotting market is projected to grow from US$ 257.05 million in 2018 to US$ 404.96 million by 2027, at a CAGR of 5.4% during the forecast period (2019-2027).

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐๐ƒ๐… ๐๐ซ๐จ๐œ๐ก๐ฎ๐ซ๐ž - https://www.businessmarketinsights.com/sample/TIPRE00006462

Key Growth Drivers:

  • Rising Investments in Proteomic Research – Increased funding and advancements in protein analysis continue to fuel market expansion.
  • Growing Prevalence of Lyme Disease & HIV – Western blot plays a crucial role in confirming diagnoses for these conditions.

However, the adoption of alternative protein detection technologies may slow market growth in the coming years.

Western Blotting & Lyme Disease Prevalence

Western blotting remains a gold standard for confirmatory testing in diagnostics and research. Lyme disease, a tick-borne illness, is a growing concern in North America. A 2018 study by Carnegie Mellon University indicated that climate change is driving an increase in Lyme disease cases across the United States. Research also suggests that western blot IgM testing offers 94-96% specificity for patients displaying clinical symptoms of Lyme disease.

As research investments rise and disease prevalence increases, the western blotting market is expected to experience steady growth.

The prevalence of HIV/AIDS has increased during recent years worldwide. Acquired immunodeficiency syndrome (AIDS) is a chronic, possibly life-threatening condition that is caused by a human immunodeficiency virus (HIV). The virus is responsible for damaging the immune system, where HIV interferes with the body's ability to fight the organisms that cause disease. As per the data provided by the US Department of Health & Human Services and supported and the Secretary’s Minority AIDS Initiative Fund (SMAIF), in 2017, approx. 36.9 million people were living worldwide with HIV/AIDS. A massive majority of people living with HIV are in low- and middle-income countries. For instance, according to the India HIV Estimation 2017 report (National Informatics Centre), in India, the prevalence of HIV is estimated at 0.22% (0.16%–0.30%). Moreover, an adult HIV prevalence is estimated at 0.25% (0.18%-0.34%) among males and at 0.19% (0.14-0.25) among Females. Western blot is used in the confirmatory test for HIV followed by ELISA test. Western blot was the specifically gold standard for the diagnosis of HIV-1 infection. According to data published on the site of HIV.gov in 2016, approximately 38,700 people were newly infected by HIV. Therefore, the above-mentioned factors help to upsurge the market in the coming years.

North America Western Blotting Strategic Insights

Strategic insights for the North America Western Blotting provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Western Blotting Report Scope

Report Attribute

Details

 

Market size in 2018

US$ 257.05 Million

 

Market Size by 2027

US$ 404.96 Million

 

Global CAGR (2019 - 2027)

5.4%

 

Historical Data

2016-2017

 

Forecast period

2019-2027

 

Segments Covered

By Product: Instruments, Consumables

 

By Application: Biomedical & Biochemical Research, Agriculture

 

By End User: Biotechnological and Pharmaceutical Companies, Diagnostic Laboratories, Academic and Research Institutes

 

Regions and Countries Covered

North America: US, Canada, Mexico

 

Market leaders and key company profiles

Thermo Fisher Scientific Inc., Merck KGaA, GENERAL ELECTRIC, Cell Signaling Technology, Inc., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., LI-COR, Inc., OriGene Technologies, Inc., Rockland Immunochemicals Inc., Abcam plc

North America Western Blotting Regional Insights

The geographic scope of the North America Western Blotting refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Dรฉfense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insight
s

Comments

Popular posts from this blog

Europe Poultry Feed Market Trends, Size, Segment and Growth by Forecast to 2030

North America Meat Extract Market Trends, Size, Segment and Growth by Forecast to 2030

Benelux Heavy Construction Equipment Market Trends, Size, Segment and Growth by Forecast to 2030